DUBLIN, 02-Jan-2018 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG), the global biotechnology leader in rare diseases, today announced that it has filed its first submission to the United States Food and Drug Administration for the company’s new plasma manufacturing … Read the full press release
Posted in Business, Healthcare, Ireland, Pharma & Biotech
DUBLIN, 21-Nov-2017 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG), the global biotech leader in rare diseases, today announced that Thomas Dittrich will join the company as Chief Financial Officer, and become an Executive member of the Board of Directors … Read the full press release
Posted in Business, Ireland, Management, Pharma & Biotech
Tagged Dr. Flemming Ornskov MD MPH, Shire plc, Thomas Dittrich
DUBLIN, 02-Aug-2017 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”), in accordance with 5.6.1R of the Financial Conduct Authority’s (the “FCA”) Disclosure Guidance and Transparency Rules, notifies the market of the following: As at July 31, 2017, the … Read the full press release
Posted in Ireland, Management, Pharma & Biotech
Tagged Sarah Rixon, Shire plc, voting rights
Lexington, Mass., USA, 20-Jan-2017 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG) announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the Class 2 resubmission of a New Drug Application (NDA) for SHP465, a long-acting, triple-bead, … Read the full press release
Posted in Healthcare, Ireland, Pharma & Biotech
Tagged ADHD, Andrew J. Cutler MD, New Drug Application, PDUFA, Philip Vickers PhD, Prescription Drug User Fee Act, Shire plc, SHP465, U.S. FDA
New system reduces number of steps in the treatment process for hemophilia A patients on ADYNOVATE [Antihemophilic Factor, (Recombinant), PEGylated] LEXINGTON, Mass., 04-Aug-2016 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG) announced that the U.S. Food and Drug Administration (FDA) … Read the full press release
Posted in Healthcare, Ireland, Pharma & Biotech
Tagged ADYNOVATE, BAXJECT III reconstitution system, Perry Sternberg, Shire plc, U.S. FDA
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
